The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Our vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
